Editorial: Antiviral drugs and vaccines against important human respiratory viruses.

Yang, Minghui; Yang, Yang; Zheng, Qingbing; Victorovich, Khrustalev Vladislav; Shen, Chenguang

Yang, Minghui; Yang, Yang; Zheng, Qingbing; Victorovich, Khrustalev Vladislav; Shen, Chenguang.

Yang M; Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Advanced Research Institute of Multidisciplinary Sciences, Beijing Institute of Technology, Beijing, China.
Yang Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Zheng Q; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China.
Victorovich KV; Department of General Chemistry, Belarusian State Medical University, Minsk, Belarus.
Shen C; BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.

Front Pharmacol ; 13: 1082652, 2022.

Article in English | MEDLINE | ID: covidwho-2287560

Keywords

antiviral agent; antiviral mechanism; host-virus interactions; human respiratory virus; molecular diagnostics; therapeutics to viral infection

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Front Pharmacol Year: 2022 Document Type: Article Affiliation country: Fphar.2022.1082652

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google